Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standardization study of Helicobacter pylori eradication regimens in children
ChiCTR1900027450Phase 4Recruiting
- Sponsor
- West China Second University Hospital
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of omeprazole, amoxicillin, clarithromycin, bismuth subsalicylate and metronidazole in Helicobacter pylori infection (4 arms), sponsored by West China Second University Hospital. Primary endpoints: Helicobacter pylori eradication result by urea breath test, Minimum inhibitory concentration values of antimicrobial agents and 1 more. Started Mar 2018; status: recruiting.
02
Drugs
omeprazoleamoxicillinclarithromycinbismuth subsalicylatemetronidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR1900027450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027450.